Ubiquitin Protein Ligase E3 Component N-Recognin 2 (UBR2)

[Edit]

C6orf133; N-recognin-2; E3 ubiquitin-protein ligase UBR2

Ubiquitin Protein Ligase E3 Component N-Recognin 2 (UBR2)
Proteolysis by the ubiquitin-proteasome system controls the concentration of many regulatory proteins. The selectivity of ubiquitylation is determined by ubiquitin E3 ligases, which recognize the substrate's destabilization signal, or degron. The E3 ligase UBR2 participates in the N-end rule pathway, which targets proteins bearing an N-terminal degron, or N-degron. The deduced 1,275-amino acid protein shares 19.9% identity over 710 amino acids with an S. cerevisiae N-end-recognizing protein. RT-PCR of several tissues detected UBR2 expression only in testis.mouse Ubr2 bound to type-1 (arg) and type-2 (leu or phe) destabilizing N-terminal residues of a test substrate or a 12-residue peptide. It did not bind to stabilizing (met or gly), secondary destabilizing (asp), or type-3 destabilizing (ser, thr, or ala) residues.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Ubiquitin Protein Ligase E3 Component N-Recognin 2 (UBR2) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Ubiquitin Protein Ligase E3 Component N-Recognin 2 (UBR2) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Ubiquitin Protein Ligase E3 Component N-Recognin 2 (UBR2) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Ubiquitin Protein Ligase E3 Component N-Recognin 2 (UBR2) CLIA Kit Customized Service Offer
n/a ELISA Kit for Ubiquitin Protein Ligase E3 Component N-Recognin 2 (UBR2) ELISA Kit Customized Service Offer

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Ubiquitin Protein Ligase E3 Component N-Recognin 2 (UBR2) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Ubiquitin Protein Ligase E3 Component N-Recognin 2 (UBR2) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Ubiquitin Protein Ligase E3 Component N-Recognin 2 (UBR2) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Ubiquitin Protein Ligase E3 Component N-Recognin 2 (UBR2) CLIA Kit Customized Service Offer
n/a ELISA Kit for Ubiquitin Protein Ligase E3 Component N-Recognin 2 (UBR2) ELISA Kit Customized Service Offer
  1. "Regulation of protein catabolism by muscle-specific and cytokine-inducible ubiquitin ligase E3alpha-II during cancer cachexia."Cancer Res. 64:8193-8198(2004) [PubMed] [Europe PMC] [Abstract]
  2. "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
  3. "The DNA sequence and analysis of human chromosome 6." Nature 425:805-811(2003) [PubMed] [Europe PMC] [Abstract]
  4. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  5. "Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro."DNA Res. 4:141-150(1997) [PubMed] [Europe PMC] [Abstract]
  6. "RECQL4, mutated in the Rothmund-Thomson and RAPADILINO syndromes, interacts with ubiquitin ligases UBR1 and UBR2 of the N-end rule pathway."Hum. Mol. Genet. 13:2421-2430(2004) [PubMed] [Europe PMC] [Abstract]
  7. "Deficiency of UBR1, a ubiquitin ligase of the N-end rule pathway, causes pancreatic dysfunction, malformations and mental retardation (Johanson-Blizzard syndrome)." Nat. Genet. 37:1345-1350(2005) [PubMed] [Europe PMC] [Abstract]
  8. "A quantitative atlas of mitotic phosphorylation."Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract]
  9. "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract]
  10. "Role of N-end rule ubiquitin ligases UBR1 and UBR2 in regulating the leucine-mTOR signaling pathway."Genes Cells 15:339-349(2010) [PubMed] [Europe PMC] [Abstract]
  11. "Initial characterization of the human central proteome."BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract]
  12. "Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features."Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012) [PubMed] [Europe PMC] [Abstract]
  13. "N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB."Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012) [PubMed] [Europe PMC] [Abstract]
  14. "Structural basis of substrate recognition and specificity in the N-end rule pathway."Nat. Struct. Mol. Biol. 17:1182-1187(2010) [PubMed] [Europe PMC] [Abstract]